CN Patent

CN1901906B — 治疗套细胞淋巴瘤的cci-779

Assigned to Mayo Foundation for Medical Education and Research · Expires 2011-11-16 · 15y expired

What this patent protects

本发明提供与3-羟基-2-(羟基甲基)-2-甲基丙酸(CCI-779)的瑞帕霉素42-酯在治疗或抑制套细胞淋巴瘤中的应用。

USPTO Abstract

本发明提供与3-羟基-2-(羟基甲基)-2-甲基丙酸(CCI-779)的瑞帕霉素42-酯在治疗或抑制套细胞淋巴瘤中的应用。

Drugs covered by this patent

Decadron (dexamethasone) · Generic (originally Merck)

Patent Metadata

Patent number: CN1901906B
Jurisdiction: CN
Classification: —
Expires: 2011-11-16
Drug substance claim: No
Drug product claim: No
Assignee: Mayo Foundation for Medical Education and Research
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.